- Actavis receives approval of generic Wellbutrin in U.S. (News-Medical-Net)
Actavis Group today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately.
- Actavis Receives Approval Of Generic Wellbutrin XL(R) 300mg In The United States (Medical News Today)
Actavis Group, the international generic pharmaceuticals company, announced that it has received approval from the US Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately.
- Patch to aid women's sex drive? (Miami Herald)
In the continuing attempts to find a treatment for women with low sexual desire, a South Miami-Dade pharmaceutical company is working with Procter & Gamble to develop a drug-bearing patch using testosterone.
- Biovail names new CFO as it moves to turn page (The Globe and Mail)
TORONTO (Reuters) - Biovail Corp , Canada's biggest publicly traded drugmaker, named Peggy Mulligan its new chief financial officer on Thursday, the fifth person to hold that position in the past four years.
- Actavis Receives Approval Of Generic Wellbutrin XL® 300mg In The U.S. (PharmaceuticalOnline)
Actavis Group, the international generic pharmaceuticals company, recently announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately.
- Actavis gets US FDA nod for generic Wellbutrin XL 300 mg (PharmaBiz)
Actavis has received approval from the US Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately.
- Actavis receives approval of generic Wellbutrin XL(R) 300mg in the United States (Marketwire via Yahoo! Finance)
Reykjavik, Iceland, 19 August 2008 - - Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets 300mg. Distribution of the product will commence immediately.
- Desire for Plastic Surgery Motivates Some Smokers to Quit (Join Together Online)
With all the smoking cessation tools available to those trying to quit, an unexpected motivator is coming from the increasingly popular world of cosmetic surgery.
- Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg in the U.S. (PR Newswire via Yahoo! Finance)
Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets 300mg.
- 'CNS Drug Discoveries: What the Future Holds 2008' Identifies 60 Drugs or Therapeutic Agents That Have the Potential ... (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of the "CNS Drug Discoveries: What the Future Holds 2008" report to their offering.